Organisation and governance


The foundation
Cure Lowe Foundation is a Danish non-profit association, founded in 2024 by Sebastian Honoré and Cecilie Bech Hammer after their son Walther was diagnosed with Lowe syndrome. CVR no. 45009572.

The board
The board sets the strategy and oversees how funds are used. Its members are Henrik Møgelmose (chair), Charlotte Møller (vice-chair), Sibel Arnes, Finn Rosenthal and Bo Hammer.

Walther Therapeutics
Walther Therapeutics ApS is the foundation’s drug development company, based at the BioInnovation Institute in Copenhagen. It runs the kidney gene therapy programme. CVR no. 45762505.

Scientific Advisory Board
Xavier Anguela, Federico Mingozzi, Harald Petry and Yang Sun advise on the science, from vector design to clinical endpoints.

Fundraising approval
Our fundraising is approved and registered with the Danish Civil Affairs Agency (Civilstyrelsen), and our fundraising accounts are audited by a state-authorised public accountant.

Meet the team  ·  Finances and transparency

Back to About us